Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK-Reference-Cited by-同舟云学术

Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK

Published:2021-01-18 Issue:1 Volume:3 Page:
ISSN:2632-1823
Container-title:JAC-Antimicrobial Resistance
language:en
Short-container-title:

Author:

Brown Nicholas M¹,Goodman Anna L²³,Horner Carolyne⁴,Jenkins Abi⁴,Brown Erwin M⁴

Affiliation:

1. Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

2. Guy’s and St Thomas’ NHS Foundation Trust, London, UK

3. MRC Clinical Trials Unit, University College London, London, UK

4. British Society for Antimicrobial Chemotherapy, Birmingham, UK

Abstract

Abstract These evidence-based guidelines are an updated version of those issued in 2008. They have been produced following a review of the published literature (2007–18) pertaining to the treatment of infections caused by MRSA. The guidelines update, where appropriate, previous recommendations, taking into account changes in the UK epidemiology of MRSA, ongoing national surveillance data and the efficacy of novel anti-staphylococcal agents licensed for use in the UK. Emerging therapies that have not been licensed for use in the UK at the time of the review have also been assessed.

Funder

BSAC

British Infection Association

Healthcare Infection Society

Infection Prevention Society

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/jacamr/article-pdf/3/1/dlaa114/38269506/dlaa114.pdf

Reference51 articles.